77 King St W, Suite 400, Toronto-Dominion Ctr, Toronto, ON
Year called to bar: 2007 (ON)
Eric Foster's practice focuses on corporate finance, mergers & acquisitions (public and private), regulatory compliance, cannabis law and emerging companies. Eric routinely acts as counsel to both public and private issuers and securities dealers, with a particular focus on the cannabis, mining, life sciences, real estate and technology sectors. Eric is the head of Dentons’ Canadian cannabis practice and is recognized as one of Canada’s leading cannabis lawyers. Eric's corporate finance practice involves advising issuers, securities dealers and institutional investors in a wide range of financing transactions, including IPOs, secondary offerings, private placements and other forms of equity and debt financing. In his M&A practice, Eric advises acquirers and target companies involved in friendly and hostile takeover bids, plans of arrangement, reverse takeovers and other business combination transactions. Eric has acted on several of the largest and most well-publicized transactions in the cannabis industry and has experience with complex commercial agreements for cannabis industry participants including cannabis licensing, royalty, supply, consulting and celebrity partnership agreements.
On April 21, 2015, Concordia Healthcare Corp. (Concordia), a diverse healthcare company focused on legacy pharmaceutical products and orphan drugs, acquired 18 products from Covis Pharma S.à.r.l and Covis Injectables, S.à.r.l (collectively, Covis). The purchase price of US$1.2 billion was paid in cash at closing.